These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2588952

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
    Glaser M.
    Med Sci Monit; 2006 Mar; 12(3):CR113-7. PubMed ID: 16501421
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.
    Lu L, Pelus LM, Broxmeyer HE.
    Exp Hematol; 1984 Oct; 12(9):741-8. PubMed ID: 6436046
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Growth kinetics of CFU-GEMM, BFU-E, and CFU-C in diffusion-chamber cultures of normal human bone marrow cells.
    Ganser A, Hoelzer D.
    Exp Hematol; 1984 Oct; 12(9):712-6. PubMed ID: 6489482
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy.
    Roodman GD, LeMaistre CF, Clark GM, Page CP, Newcomb TF, Knight WA.
    Bone Marrow Transplant; 1987 Aug; 2(2):165-73. PubMed ID: 3332164
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Survival of highly proliferative colony forming cells after treatment of bone marrow cells with 4-hydroperoxycyclophosphamide.
    Komatsu N, Suda T, Suda J, Miura Y.
    Cancer Res; 1987 Dec 01; 47(23):6371-6. PubMed ID: 3677081
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders.
    Hibbin JA, Njoku OS, Matutes E, Lewis SM, Goldman JM.
    Br J Haematol; 1984 Jul 01; 57(3):495-503. PubMed ID: 6743569
    [Abstract] [Full Text] [Related]

  • 15. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug 01; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Methods for measuring suppression of hematopoiesis.
    Chervenick PA.
    Exp Hematol; 1985 Aug 01; 13 Suppl 16():8-15. PubMed ID: 3987838
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC, Brufau A, Mota A, Lopez N, Fernandez ME, Vallejo C, Hernandez JM, Garcia JL, San Miguel JF.
    Haematologica; 1998 Jan 01; 83(1):3-7. PubMed ID: 9580461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.